| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1084924087 |
| P356 | DOI | 10.1186/S13287-017-0540-3 |
| P932 | PMC publication ID | 5395912 |
| P698 | PubMed publication ID | 28420434 |
| P50 | author | Ahmed A Rahman | Q64038182 |
| Kulmira Nurgali | Q50149515 | ||
| Samy Sakkal | Q57003056 | ||
| P2093 | author name string | Sarah Miller | |
| Ainsley M Robinson | |||
| Rhian Stavely | |||
| P2860 | cites work | Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review | Q22250934 |
| Mesenchymal stem cells and immunomodulation: current status and future prospects | Q26770191 | ||
| The challenges and promises of allogeneic mesenchymal stem cells for use as a cell-based therapy | Q26775933 | ||
| Immunological characteristics of human mesenchymal stem cells and multipotent adult progenitor cells | Q26852467 | ||
| Treatment of inflammatory bowel disease (IBD) | Q26853183 | ||
| Neuroprotective Potential of Mesenchymal Stem Cell-Based Therapy in Acute Stages of TNBS-Induced Colitis in Guinea-Pigs | Q27316366 | ||
| Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement | Q27861120 | ||
| Crohn's disease | Q28273481 | ||
| Mesenchymal stem cells in health and disease | Q29614296 | ||
| Inflammatory bowel disease | Q29616286 | ||
| Mesenchymal stem cells as trophic mediators | Q29619806 | ||
| Epidemiology and natural history of inflammatory bowel diseases | Q29619945 | ||
| Clinical applications of mesenchymal stem cells in chronic diseases | Q30437823 | ||
| Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial | Q31033745 | ||
| Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing | Q33326623 | ||
| Neurochemical coding in the small intestine of patients with Crohn's disease. | Q33618209 | ||
| Myogenic lineage differentiated mesenchymal stem cells enhance recovery from dextran sulfate sodium-induced colitis in the rat. | Q33694464 | ||
| Mesenchymal stem cells derived from human gingiva are capable of immunomodulatory functions and ameliorate inflammation-related tissue destruction in experimental colitis | Q33898618 | ||
| Mesenchymal stem cell therapy: Two steps forward, one step back | Q33898653 | ||
| Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery | Q34012747 | ||
| Distinct role of gp130 activation in promoting self-renewal divisions by mitogenically stimulated murine hematopoietic stem cells | Q34102346 | ||
| Consequences of intestinal inflammation on the enteric nervous system: neuronal activation induced by inflammatory mediators. | Q34123459 | ||
| Intraperitoneal but not intravenous cryopreserved mesenchymal stromal cells home to the inflamed colon and ameliorate experimental colitis | Q34202877 | ||
| Mesenchymal stem or stromal cells: a review of clinical applications and manufacturing practices. | Q34422955 | ||
| Inflammatory bowel disease: clinical aspects and treatments | Q34431476 | ||
| Mesenchymal stem cells at the intersection of cell and gene therapy | Q34676808 | ||
| Mesenchymal stem cell therapy stimulates endogenous host progenitor cells to improve colonic epithelial regeneration | Q34906406 | ||
| Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies | Q34992075 | ||
| Negative impact of bone-marrow-derived mesenchymal stem cells on dextran sulfate sodium-induced colitis | Q35078005 | ||
| Colitis-induced neuroplasticity disrupts motility in the inflamed and post-inflamed colon | Q35183955 | ||
| Changes in chemical coding of myenteric neurones in ulcerative colitis | Q35595304 | ||
| The fundamental basis of inflammatory bowel disease | Q35649436 | ||
| A Phase I Clinical Trial of the Treatment of Crohn's Fistula by Adipose Mesenchymal Stem Cell Transplantation | Q59395439 | ||
| Differential responses of VIPergic and nitrergic neurons in paediatric patients with Crohn's disease | Q59497149 | ||
| The selective beneficial effects of nitric oxide inhibition in experimental colitis | Q59497204 | ||
| Ligand/Receptor Signaling Threshold (LIST) Model Accounts for gp130-Mediated Embryonic Stem Cell Self-Renewal Responses to LIF and HIL-6 | Q62658874 | ||
| Structural abnormalities of the nervous system in Crohn's disease and ulcerative colitis | Q74769387 | ||
| Optimal temporal delivery of bone marrow mesenchymal stem cells in rats with myocardial infarction | Q79615008 | ||
| Topical implantation of mesenchymal stem cells has beneficial effects on healing of experimental colitis in rats | Q81192912 | ||
| Enteric nervous system abnormalities in inflammatory bowel diseases | Q81309250 | ||
| Autologous mesenchymal stem cell transplantation in stroke patients | Q81803888 | ||
| Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses | Q83171181 | ||
| Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis | Q83172279 | ||
| Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease | Q83272771 | ||
| Differentiation of mesenchymal stem cells to support peripheral nerve regeneration in a rat model | Q83331661 | ||
| Human umbilical cord mesenchymal stem cells ameliorate mice trinitrobenzene sulfonic acid (TNBS)-induced colitis | Q83591296 | ||
| Bone marrow mesenchymal stem cells suppress lymphocyte proliferation in vitro but fail to prevent graft-versus-host disease in mice | Q83918286 | ||
| Ulcerative colitis | Q84851901 | ||
| A phase 2 study of allogeneic mesenchymal stromal cells for luminal Crohn's disease refractory to biologic therapy | Q47968884 | ||
| Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study | Q48321211 | ||
| Bone marrow stromal cells reduce axonal loss in experimental autoimmune encephalomyelitis mice | Q48497239 | ||
| Adipose stromal cells-secreted neuroprotective media against neuronal apoptosis | Q48556903 | ||
| Phenotypic changes of morphologically identified guinea-pig myenteric neurons following intestinal inflammation | Q48585316 | ||
| Persistent alterations to enteric neural signaling in the guinea pig colon following the resolution of colitis | Q48659218 | ||
| Mesenchymal Stem Cells Reduce Colitis in Mice via Release of TSG6, Independently of Their Localization to the Intestine. | Q50437860 | ||
| Over-expression of CXCR4 on mesenchymal stem cells protect against experimental colitis via immunomodulatory functions in impaired tissue. | Q50470957 | ||
| Allogeneic Bone Marrow-Derived Mesenchymal Stromal Cells Promote Healing of Refractory Perianal Fistulas in Patients With Crohn's Disease. | Q50541878 | ||
| Exogenous administration of mesenchymal stem cells ameliorates dextran sulfate sodium-induced colitis via anti-inflammatory action in damaged tissue in rats. | Q50616625 | ||
| Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. | Q50767537 | ||
| Report: economic implications of inflammatory bowel disease and its management. | Q50801742 | ||
| Osteogenic and chondrogenic differentiation: comparison of human and rat bone marrow mesenchymal stem cells cultured into polymeric scaffolds. | Q50891171 | ||
| Expanded adipose-derived stem cells for the treatment of complex perianal fistula: a phase II clinical trial. | Q51775892 | ||
| Gene expression profile of mouse bone marrow stromal cells determined by cDNA microarray analysis. | Q52953000 | ||
| Mesenchymal stem cells and conditioned medium avert enteric neuropathy and colon dysfunction in guinea pig TNBS-induced colitis. | Q53419188 | ||
| Mesenchymal stromal cells inhibit graft-versus-host disease of mice in a dose-dependent manner. | Q53482789 | ||
| Modulation of nuclear factor-κB-mediated pro-inflammatory response is associated with exogenous administration of bone marrow-derived mesenchymal stem cells for treatment of experimental colitis. | Q53674126 | ||
| Systemic infusion of bone marrow-derived mesenchymal stem cells for treatment of experimental colitis in mice. | Q54302606 | ||
| Murine bone marrow derived stromal progenitor cells fail to prevent or treat acute graft-versus-host disease. | Q54543616 | ||
| Axonal necrosis of enteric autonomic nerves in continent ileal pouches. Possible implications for pathogenesis of Crohn's disease. | Q54661481 | ||
| The Value of Myenteric Plexitis to Predict Early Postoperative Crohn’s Disease Recurrence | Q57265437 | ||
| Inflammatory conditions affect gene expression and function of human adipose tissue-derived mesenchymal stem cells | Q57619027 | ||
| Adipose-derived mesenchymal stromal cells induce immunomodulatory macrophages which protect from experimental colitis and sepsis | Q58862703 | ||
| New strategies for overcoming limitations of mesenchymal stem cell-based immune modulation | Q35653672 | ||
| Extracellular Vesicles Derived from Bone Marrow Mesenchymal Stem Cells Protect against Experimental Colitis via Attenuating Colon Inflammation, Oxidative Stress and Apoptosis | Q35808157 | ||
| Human cord blood-derived platelet lysate enhances the therapeutic activity of adipose-derived mesenchymal stromal cells isolated from Crohn's disease patients in a mouse model of colitis | Q36045296 | ||
| The potential of mesenchymal stromal cells as a novel cellular therapy for multiple sclerosis | Q36054671 | ||
| Human adult stem cells derived from adipose tissue and bone marrow attenuate enteric neuropathy in the guinea-pig model of acute colitis. | Q36361561 | ||
| Allogeneic guinea pig mesenchymal stem cells ameliorate neurological changes in experimental colitis. | Q36419634 | ||
| From cytogenomic to epigenomic profiles: monitoring the biologic behavior of in vitro cultured human bone marrow mesenchymal stem cells. | Q36633035 | ||
| Stem/progenitor cells from bone marrow decrease neuronal death in global ischemia by modulation of inflammatory/immune responses | Q36936307 | ||
| Mesenchymal stem cells alleviate TNBS-induced colitis by modulating inflammatory and autoimmune responses | Q37068242 | ||
| Mesenchymal stem cells as therapeutics | Q37138080 | ||
| Human umbilical cord-derived mesenchymal stem cells protect against experimental colitis via CD5(+) B regulatory cells | Q37169313 | ||
| Direct muscle delivery of GDNF with human mesenchymal stem cells improves motor neuron survival and function in a rat model of familial ALS | Q37183861 | ||
| The safety of biologic agents in the treatment of inflammatory bowel disease | Q37212079 | ||
| Mesenchymal stem cell homing: the devil is in the details | Q37407769 | ||
| Monitoring the genomic stability of in vitro cultured rat bone-marrow-derived mesenchymal stem cells | Q37475659 | ||
| Paradoxical regulation of ChAT and nNOS expression in animal models of Crohn's colitis and ulcerative colitis | Q37476404 | ||
| A comparison of adipose and bone marrow-derived mesenchymal stromal cell secreted factors in the treatment of systemic inflammation | Q37493460 | ||
| Adipose tissue derived stem cells secretome: soluble factors and their roles in regenerative medicine. | Q37639376 | ||
| The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study Group | Q37677911 | ||
| Mesenchymal stem cells: a new trend for cell therapy | Q37729093 | ||
| MSCs: Biological characteristics, clinical applications and their outstanding concerns | Q37781509 | ||
| Mesenchymal Stem Cells: Mechanisms of Inflammation | Q37809081 | ||
| Mapping of the secretome of primary isolates of mammalian cells, stem cells and derived cell lines | Q37829411 | ||
| Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC. | Q37875244 | ||
| Therapeutic drug monitoring of biologics for inflammatory bowel disease | Q37948705 | ||
| Bone marrow stem cell derived paracrine factors for regenerative medicine: current perspectives and therapeutic potential. | Q37951953 | ||
| The enteric nervous system and neurogastroenterology. | Q37990818 | ||
| Do mesenchymal stem cells function across species barriers? Relevance for xenotransplantation. | Q38043528 | ||
| Mesenchymal stromal cells: sensors and switchers of inflammation | Q38149359 | ||
| Mesenchymal stem cell trials for pulmonary diseases | Q38187078 | ||
| Mesenchymal stem cells: potential in treatment of neurodegenerative diseases | Q38253549 | ||
| Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications | Q38261365 | ||
| Human Bone Marrow- and Adipose Tissue-derived Mesenchymal Stromal Cells are Immunosuppressive In vitro and in a Humanized Allograft Rejection Model. | Q38439453 | ||
| Biological differences between native and cultured mesenchymal stem cells: implications for therapies | Q39099659 | ||
| Systemic treatment with adipose-derived mesenchymal stem cells ameliorates clinical and pathological features in the amyotrophic lateral sclerosis murine model. | Q39144950 | ||
| The possible role of mesenchymal stem cells therapy in the repair of experimentally induced colitis in male albino rats | Q39280447 | ||
| Immunological characteristics of mesenchymal stem cells | Q39723551 | ||
| Common and distinct features of cytokine effects on hematopoietic stem and progenitor cells revealed by dose-response surface analysis | Q40630819 | ||
| Mesenchymal stem cells recruit macrophages to alleviate experimental colitis through TGFβ1. | Q41509845 | ||
| Injured Nerve Regeneration using Cell-Based Therapies: Current Challenges | Q41872390 | ||
| Transplantable marrow osteoprogenitors engraft in discrete saturable sites in the marrow microenvironment | Q41900619 | ||
| Expanded allogeneic adipose-derived stem cells (eASCs) for the treatment of complex perianal fistula in Crohn's disease: results from a multicenter phase I/IIa clinical trial | Q42672137 | ||
| Damage to the enteric nervous system in experimental colitis | Q42795005 | ||
| Mesengenic differentiation: comparison of human and rat bone marrow mesenchymal stem cells | Q43046308 | ||
| Autologous adipose tissue-derived stem cells for the treatment of Crohn's fistula: a phase I clinical study | Q43526778 | ||
| TGF-beta signaling-dependent alleviation of dextran sulfate sodium-induced colitis by mesenchymal stem cell transplantation | Q43736820 | ||
| Morphological and functional alterations of the myenteric plexus in rats with TNBS-induced colitis | Q43793241 | ||
| Human umbilical cord blood mesenchymal stem cells reduce colitis in mice by activating NOD2 signaling to COX2. | Q43906393 | ||
| Autologous adipose tissue-derived stem cells treatment demonstrated favorable and sustainable therapeutic effect for Crohn's fistula | Q44012199 | ||
| Enhanced excitability of myenteric AH neurones in the inflamed guinea-pig distal colon | Q44300149 | ||
| Plexitis as a predictive factor of early postoperative clinical recurrence in Crohn's disease. | Q44369858 | ||
| Dose-dependent efficacy of ALS-human mesenchymal stem cells transplantation into cisterna magna in SOD1-G93A ALS mice | Q44472268 | ||
| Pretreatment with interferon-γ enhances the therapeutic activity of mesenchymal stromal cells in animal models of colitis | Q45120168 | ||
| Myenteric plexus injury and apoptosis in experimental colitis. | Q45202738 | ||
| MSC-based product characterization for clinical trials: an FDA perspective | Q45862249 | ||
| Slow synaptic transmission in myenteric AH neurons from the inflamed guinea pig ileum. | Q45952546 | ||
| Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression. | Q45959326 | ||
| Structural changes in the epithelium of the small intestine and immune cell infiltration of enteric ganglia following acute mucosal damage and local inflammation. | Q45973882 | ||
| Enhancing epithelial engraftment of rat mesenchymal stem cells restores epithelial barrier integrity. | Q46085911 | ||
| Morphological and functional changes in guinea-pig neurons projecting to the ileal mucosa at early stages after inflammatory damage. | Q46159896 | ||
| Phenotype and chondrogenic differentiation of mesenchymal cells from adipose tissue of different species. | Q46175296 | ||
| Neuroprotective effects of human mesenchymal stem cells on dopaminergic neurons through anti-inflammatory action | Q46459547 | ||
| Indiscriminate loss of myenteric neurones in the TNBS-inflamed guinea-pig distal colon | Q46632504 | ||
| Subcutaneous adipose tissue-derived stem cells facilitate colonic mucosal recovery from 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced colitis in rats | Q46769226 | ||
| Changes in colonic motility and the electrophysiological properties of myenteric neurons persist following recovery from trinitrobenzene sulfonic acid colitis in the guinea pig. | Q46921550 | ||
| Human mesenchymal stem cells license adult CD34+ hemopoietic progenitor cells to differentiate into regulatory dendritic cells through activation of the Notch pathway. | Q47966993 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 87 | |
| P577 | publication date | 2017-04-18 | |
| P1433 | published in | Stem Cell Research & Therapy | Q14390536 |
| P1476 | title | The neuroprotective effects of human bone marrow mesenchymal stem cells are dose-dependent in TNBS colitis | |
| P478 | volume | 8 |
| Q58792475 | Differential and Interactive Effects of Substrate Topography and Chemistry on Human Mesenchymal Stem Cell Gene Expression |
| Q64238218 | Human parthenogenetic neural stem cell grafts promote multiple regenerative processes in a traumatic brain injury model |
| Q92827333 | Intercellular adhesion molecule-1 enhances the therapeutic effects of MSCs in a dextran sulfate sodium-induced colitis models by promoting MSCs homing to murine colons and spleens |
| Q92224628 | Mesenchymal stem cell-gut microbiota interaction in the repair of inflammatory bowel disease: an enhanced therapeutic effect |
| Q61454884 | Systematic Exposition of Mesenchymal Stem Cell for Inflammatory Bowel Disease and Its Associated Colorectal Cancer |
| Q57538743 | The Use of Human Mesenchymal Stem Cells as Therapeutic Agents for the Treatment of Immune-Related Diseases: A Systematic Review |
Search more.